Delaware/Christiana Care community Oncology Research Program

描述（由申请人提供）：特拉华/克里斯蒂安娜护理（CCHS）社区肿瘤研究项目最初于1987年作为社区临床肿瘤项目（CCOP）获得资助，并于2007年开始作为NCI社区癌症中心项目获得资助，并一直是这两个项目的典范贡献者。目前，CCHS参与了NRG、ALLIANCE、ECOG-ACRIN、Wake Forest和Rochester合作小组。CCOP继续履行合作小组遗留小组的研究义务，包括：CALGB， NSABP， ECOG， RTOG， GOG， Wake Forest和URCC。对CTSU的参与是积极和持续的。我们广泛的集水区包括特拉华州和新泽西州的部分地区，马里兰州东北部和宾夕法尼亚州东南部（特拉华州和切斯特县）。特拉华州在全国所有癌症部位疾病发病率中排名第三，马里兰州排名第35，新泽西州排名第5，宾夕法尼亚州排名第6（2007年使用数据）。我们的研究基地代表了超过200万人的人口基数，具有广泛的协议进入潜力。在Stephen S.Grubbs，医学博士，首席研究员，Gregory Masters，医学博士，联合首席研究员和Kandie Dempsey， MS， RN， OCN，主任，CCOP调查员，项目协调员和数据经理将继续参与国家临床试验网络（NCTN）核心委员会和领导职位。我们的使命是继续累积治疗和癌症控制研究，并进一步发展癌症护理交付研究（CCDR）的参与，这将建立在我们在NCCCP合作的倡议基础上。我们预计将至少10%的活动用于CCDR，包括对社会因素、组织结构和流程、卫生技术、癌症治疗的可及性、质量和成本因素、社区差异的复杂性进行科学调查。并将研究作为CCDR项目的一部分审查护理和卫生技术系统财务成本的可行性。这笔赠款的总体影响将是确保在整个集水区的Christiana保健服务机构及其附属机构继续开展和促进CCOP活动，包括治疗和癌症控制研究。特拉华/CCHS CCOP在全国临床试验项目中一直名列前茅。在过去的三年里，2010年的应计利率为24.8%，2011年为24%，2012年为21.4%。

DESCRIPTION (provided by applicant): Delaware/Christiana Care (CCHS) Community Oncology Research Program was originally funded as a Community Clinical Oncology Program (CCOP) in 1987, and was funded as a NCI Community Cancer Centers Program beginning in 2007 and has been an exemplary contributor to both programs. Currently, CCHS participates in the NRG, ALLIANCE, ECOG-ACRIN, Wake Forest and Rochester cooperative groups. The CCOP continues to fulfill research obligations for the cooperative group legacy groups including: CALGB, NSABP, ECOG, RTOG, GOG, Wake Forest and URCC. Participation in CTSU is active and ongoing. Our extensive catchment area includes all of Delaware and portions of New Jersey, northeastern Maryland and southeastern Pennsylvania (Delaware and Chester counties). Delaware ranks 3rd in the nation for all cancer site disease incidence, Maryland ranks 35th, New Jersey 5th and Pennsylvania 6th (2007 uses Data). Our research base represents a population base in excess of 2 million people with extensive protocol entry potential. Under the leadership of Stephen S.Grubbs, M.D., Principal Investigator, Gregory Masters, M.D, Co-Principal Investigator and Kandie Dempsey, MS, RN, OCN, Director, CCOP investigators, project coordinators and data managers will continue to participate in National Clinical Trial network (NCTN) core committees and leadership positions. Our mission is to continue accruals to both treatment and cancer control studies and to further develop Cancer Care Delivery Research (CCDR) participation which will build upon the initiatives set forth with our collaboration in NCCCP. We anticipate dedicating at minimum 10% of our activities towards CCDR to include scientific investigation of the complexities of social factors, organizational structures and processes, health technologies, access to cancer care, quality and cost factors, disparities in our community. And will examine the feasibility of examining financial costs of care and health technology systems as part of the CCDR program. The overall impact of this grant will be to ensure continuation and stimulate expansion of CCOP activities, including treatment and cancer control research, at Christiana Care Health Services and its affiliates throughout the catchment area. The Delaware/CCHS CCOP has consistently rated amongst top in the nation for clinical trial accruals. Over the past three years the accrual rate has been 24.8% in 2010, 24% in 2011 and 21.4% in 2012.